Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Change in Inventory (2016 - 2025)

Bio-Techne has reported Change in Inventory over the past 17 years, most recently at $1.9 million for Q4 2025.

  • Quarterly results put Change in Inventory at $1.9 million for Q4 2025, down 78.23% from a year ago — trailing twelve months through Dec 2025 was $22.4 million (up 36.82% YoY), and the annual figure for FY2025 was $18.1 million, up 27.64%.
  • Change in Inventory for Q4 2025 was $1.9 million at Bio-Techne, down from $14.0 million in the prior quarter.
  • Over the last five years, Change in Inventory for TECH hit a ceiling of $16.0 million in Q2 2022 and a floor of -$173000.0 in Q1 2025.
  • Median Change in Inventory over the past 5 years was $4.9 million (2023), compared with a mean of $5.9 million.
  • Biggest five-year swings in Change in Inventory: skyrocketed 513.82% in 2021 and later tumbled 886.36% in 2025.
  • Bio-Techne's Change in Inventory stood at $5.7 million in 2021, then skyrocketed by 34.24% to $7.7 million in 2022, then tumbled by 43.19% to $4.4 million in 2023, then skyrocketed by 104.27% to $8.9 million in 2024, then plummeted by 78.23% to $1.9 million in 2025.
  • The last three reported values for Change in Inventory were $1.9 million (Q4 2025), $14.0 million (Q3 2025), and $6.6 million (Q2 2025) per Business Quant data.